Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Kritika Sarmah

Moderna (MRNA) vs. Amicus Therapeutics (FOLD): Which Biotech Stock Should You Add to Your Portfolio?

In this article, I have evaluated two biotech stocks, Moderna, Inc. (MRNA) and Amicus Therapeutics, Inc. (FOLD), to determine which has better upside potential. Based on the fundamental comparison of these stocks, I find FOLD a better addition to one's portfolio.

The biotechnology market is expanding due to increasing cases of target diseases and genetic disorders, along with advancements in PCR technologies and portable instruments. The global biotechnology market is poised to grow at a CAGR of 8.7% until 2030.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.